Inspra Helps, Natrecor Useless for Heart Patients
By wchung | 07 Apr, 2026
There’s good news for millions of people with mild or moderate heart failure. Studies show that the Pfizer drug Inspra and an implanted device from Medtronic can boost survival and cut down on trips to the hospital.
However, another drug that has been used for nearly a decade, Johnson & Johnson’s Natrecor (NAY’-treh-kor), did little to help people with severe heart failure in a study aimed at resolving safety concerns. Doctors say the drug seems safe but does not markedly help shortness of breath or save lives.
The studies were presented Sunday at an American Heart Association conference in Chicago.
MARILYNN MARCHIONE, AP Medical Writer CHICAGO
Articles
- US Crude Premiums Hits Record Levels as Asia, Europe Compete for Supply
- China Targets Taiwan's Chip Prowess to Avoid 'Containment' Says Taipei
- Nvidia's Buy of Main Supercomputer Software Raises AI Chip Neutrality Concerns
- SpaceX Plans Early June Pre-IPO Roadshow
- OpenAI's Jason Kwon Asks State AGs to Probe Musk's 'Anti-Competitive Behavior’
- Broadcom Scores Long-Term Deal to Develop Custom AI Chips for Google
- Samsung Q1 Profits Surge 8-Fold on AI Demand
- Judge Tana Lin Dismisses Lead-Scare Class Action Against Stanley Tumblers
- Fed Governors See Urgent Inflation Warning Signs
- Trump Continues Uncontrolled Trash Talking